NCT06973499View on ClinicalTrials.gov

Exploratory Study of the Microbiome of Upper Gastrointestinal in the Pathogenesis of Multiple Primary Lung Cancer

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

January 6, 2023

Primary Completion Date

May 30, 2024

Study Completion Date

December 25, 2024

Conditions
Multiple Primary Lung CancerMicrobial Colonization
Interventions
DIAGNOSTIC_TEST

Microbiome Profiling and Symptom Assessment

"GERD symptom assessment: Standardized GERD-Q questionnaire to evaluate reflux symptoms (heartburn, acid regurgitation) and high-risk behaviors.~Microbiome analysis: 16S rDNA sequencing of upper gastrointestinal and intratumoral microbiota."

Trial Locations (1)

100080

Beijing Haidian Hospital, Beijing

All Listed Sponsors
lead

Beijing Haidian Hospital

OTHER